Literature DB >> 22108382

Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

Michelle L Meyer1, Angela M Malek, Robert A Wild, Mary T Korytkowski, Evelyn O Talbott.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder associated with cardiovascular disease (CVD) risk factors and metabolic disturbances. This systematic review and meta-analysis was conducted to determine whether carotid intima-media thickness (CIMT), a marker of subclinical atherosclerosis, is higher in women with PCOS compared with women without PCOS.
METHODS: Primary articles reporting the mean CIMT in women with PCOS and controls were identified using Ovid MEDLINE, EMBASE and PUBMED. We performed a random-effects meta-analysis and created forest plots of the mean difference in CIMT and conducted tests for heterogeneity and publication bias. Studies were grouped by quality, defined by reporting reproducibility of CIMT and averaging both common carotid arteries versus one side for CIMT.
RESULTS: From the 36 eligible full-text studies, 8 studies were included in the systematic review and 19 studies were included in the meta-analysis (total n= 1123 women with PCOS, n= 923 controls). The summary mean difference in CIMT among women with PCOS compared with controls was 0.072 mm [95% confidence interval (CI) 0.040, 0.105, P < 0.0001] for highest quality studies, 0.084 mm (95% CI 0.042, 0.126, P = 0.0001) for good quality studies, 0.041 (95% CI -0.038, 0.120, P = 0.310) for fair-quality studies and 0.045 (95% CI -0.020, 0.111, P = 0.173) for lower quality studies.
CONCLUSIONS: Larger studies with a well-defined PCOS population using rigorous methodology may be required to draw a more robust conclusion. However, these results suggest women with PCOS are at a greater risk of premature atherosclerosis, which emphasizes the importance of screening and monitoring CVD risk factors in women with PCOS.

Entities:  

Mesh:

Year:  2011        PMID: 22108382      PMCID: PMC3383099          DOI: 10.1093/humupd/dmr046

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  75 in total

Review 1.  Metformin for the treatment of the polycystic ovary syndrome.

Authors:  John E Nestler
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

2.  Predictors of carotid intima-media thickness progression in young adults: the Bogalusa Heart Study.

Authors:  Heather M Johnson; Pamela S Douglas; Sathanur R Srinivasan; M Gene Bond; Rong Tang; Shengxu Li; Wei Chen; Gerald S Berenson; James H Stein
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

3.  Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.

Authors:  I J Ketel; C D Stehouwer; R M Henry; E H Serné; P Hompes; R Homburg; Y M Smulders; C B Lambalk
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

Review 4.  Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.

Authors:  Winifred Mak; Anuja Dokras
Journal:  Semin Thromb Hemost       Date:  2009-10       Impact factor: 4.180

5.  A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries.

Authors:  Rachel P Wildman; Laura L Schott; Sarah Brockwell; Lewis H Kuller; Kim Sutton-Tyrrell
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

6.  Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries.

Authors:  Kalpana Lakhani; Paul Hardiman; Alexander M Seifalian
Journal:  Atherosclerosis       Date:  2004-08       Impact factor: 5.162

7.  Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population.

Authors:  Charles J Glueck; John A Morrison; Naila Goldenberg; Ping Wang
Journal:  Metabolism       Date:  2009-05       Impact factor: 8.694

8.  Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome.

Authors:  Sarama Saha; Chandan Sarkar; Subhash Chandra Biswas; R Karim
Journal:  Indian J Clin Biochem       Date:  2008-10-01

Review 9.  Not all women diagnosed with PCOS share the same cardiovascular risk profiles.

Authors:  Vuk P Jovanovic; Enrico Carmina; Rogerio A Lobo
Journal:  Fertil Steril       Date:  2009-06-06       Impact factor: 7.329

10.  Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances.

Authors:  M Karadeniz; M Erdoğan; S Tamsel; A Zengi; G E Alper; O Cağlayan; F Saygili; C Yilmaz
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-04       Impact factor: 2.949

View more
  37 in total

1.  Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.

Authors:  Anna Krentowska; Agnieszka Łebkowska; Małgorzata Jacewicz-Święcka; Justyna Hryniewicka; Monika Leśniewska; Agnieszka Adamska; Irina Kowalska
Journal:  Endocrine       Date:  2021-01-13       Impact factor: 3.633

2.  The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.

Authors:  Mansooreh Samimi; Adeleh Dadkhah; Hamed Haddad Kashani; Maryam Tajabadi-Ebrahimi; Elahe Seyed Hosseini; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

3.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

4.  Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal Hyperplasia.

Authors:  Mimi S Kim; Anh Dao-Tran; Elana Davidowitz; Teresa Tseng; Vicente Gilsanz; Anna Ryabets-Lienhard; Eugene Nguyen; Mitchell E Geffner
Journal:  Horm Res Paediatr       Date:  2016-03-03       Impact factor: 2.852

5.  Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

Authors:  Kara S Hughan; Hala Tfayli; Julia G Warren-Ulanch; Emma Barinas-Mitchell; Silva A Arslanian
Journal:  J Pediatr       Date:  2015-11-03       Impact factor: 4.406

Review 6.  Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.

Authors:  Manuel Luque-Ramírez; Héctor F Escobar-Morreale
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

7.  Vascular compliance in women with polycystic ovary syndrome treated with spironolactone.

Authors:  Ozgul Muneyyirci-Delale; Sherilyne Co; Nathaniel Winer
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-14       Impact factor: 3.738

8.  The Effects of Omega-3 and Vitamin E Co-supplementation on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome.

Authors:  Hamid Reza Talari; Somayyeh Poladchang; Yaser Hamidian; Mansooreh Samimi; Hamid Reza Gilasi; Faraneh Afshar Ebrahimi; Zatollah Asemi
Journal:  Oman Med J       Date:  2018-11

Review 9.  The management of patients with polycystic ovary syndrome.

Authors:  Channa N Jayasena; Stephen Franks
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

Review 10.  Curtailing PCOS.

Authors:  Selma Feldman Witchel; Helena J Teede; Alexia S Peña
Journal:  Pediatr Res       Date:  2019-10-18       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.